Preprint · CC-BY
via bioRxiv
Attenuated replication and damaging effects of SARS-CoV-2 Omicron in an intestinal epithelial barrier model
Volcic, M., Nchioua, R., Pastorio, C., Zech, F., Read, C., Walther, P., Kirchhoff, F.
biorxiv · 2024
Abstract
Many COVID-19 patients suffer from gastrointestinal symptoms and impaired intestinal barrier function may play a key role in Long COVID. Despite its importance, the impact of SARS-CoV-2 on intestinal epithelia is poorly understood. To address this, we established an intestinal barrier model integrating epithelial Caco-2 cells, mucus-secreting HT29 cells and human Raji cells. This gut epithelial model allows efficient differentiation of Caco-2 cells into microfold-like cells, faithfully mimics intestinal barrier function, and is highly permissive to SARS-CoV-2 infection. Early strains of SARS-CoV-2 and the Delta variant replicated with high efficiency, severely disrupted barrier function, and depleted tight junction proteins, such as claudin-1, occludin and ZO-1. In comparison, Omicron subvariants also depleted ZO-1 from tight junctions but had fewer damaging effects on mucosal integrity and barrier function. Remdesivir and the TMPRSS2 inhibitor Camostat prevented SARS-CoV-2 replication and thus epithelial barrier damage, while the Cathepsin inhibitor E64d was ineffective. Our results support that SARS-CoV-2 disrupts intestinal barrier function but further suggest that circulating Omicron variants are less damaging than earlier viral strains.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- bioRxiv
- DOI
- 10.1101/2024.02.28.582510
- Canonical
- link ↗
- Fetched
- 2026-10-11 MST
Cite this
APA
M., V., R., N., C., P., F., Z., C., R., P., W., & F., K. (2024). Attenuated replication and damaging effects of SARS-CoV-2 Omicron in an intestinal epithelial barrier model. <em>biorxiv</em>. https://doi.org/10.1101/2024.02.28.582510
Vancouver
M. V, R. N, C. P, F. Z, C. R, P. W, et al. Attenuated replication and damaging effects of SARS-CoV-2 Omicron in an intestinal epithelial barrier model. biorxiv. 2024. doi:10.1101/2024.02.28.582510.
BibTeX
@unpublished{volcic2024Attenu,
title = {Attenuated replication and damaging effects of SARS-CoV-2 Omicron in an intestinal epithelial barrier model},
author = {Volcic, M. and Nchioua, R. and Pastorio, C. and Zech, F. and Read, C. and Walther, P. and Kirchhoff, F.},
journal = {biorxiv},
year = {2024},
doi = {10.1101/2024.02.28.582510},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Crohn s and Colitis 2023
Open access · CC-BY
Spermidine Ameliorates Colitis via Induction of Anti-Inflammatory Macrophages and Prevention of Intestinal Dysbiosis
Military Medical Research 2017
Open access · CC-BY
Interaction between the gut microbiome and mucosal immune system
bioRxiv (Cold Spring Harbor Laboratory) 2024
Preprint · OA
Inhibition of the metalloprotease ADAM19 as a Novel Senomorphic Strategy to Ameliorate gut permeability and senescence markers by modulating senescence-associated secretory phenotype (SASP)
Journal of Oral Biology and Craniofacial Research 2024
Open access · CC-BY
Senescence and fibrosis in salivary gland aging and disease
Cell Proliferation 2023
Open access · CC-BY
Neutrophil extracellular traps aggravate intestinal epithelial necroptosis in ischaemia–reperfusion by regulating TLR4 / RIPK3 / FUNDC1 ‐required mitophagy
Circulation Research 2011
Open access · OA